Science Explorer Back to mapMap
Discussion
Researcher · Merck KGaA, Darmstadt (Germany) · Germany

Kevin M. Chin

Kevin M. Chin publishes mostly in Oncology, Immunology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Immunotherapy and Immune Responses.

ORCID 0000-0002-5062-4159 OpenAlex
World rank
#547,492
of 7,710,434 ranked researchers
Rank in Germany
#26,970
of 364,343
Works
102
Citations
7.5k
Citations per work
73.4
h-index
29
i10-index 44Top 12% in Oncology
Kevin M. Chin

What does Kevin M. Chin research?

Kevin M. Chin's work is mostly in Medicine (64%), Immunology and Microbiology (11%).

Health Sciences: 65 works · 63.5% of their workMedicine: 65 works · 63.5% of their workOncology: 41 works · 39.8% of their workPulmonary and Respiratory Medicine: 8 works · 8.2% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 5.9% of their workSurgery: 6 works · 5.9% of their workPathology and Forensic Medicine: 4 works · 3.7% of their workEverything else: 26 works · 25.3% of their workLife Sciences: 11 works · 11.2% of their workImmunology and Microbiology: 11 works · 11.2% of their workImmunology: 11 works · 11.2% of their workTHEIR WORKKevin M. Chin102works
Life Sciences11%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6563.5%
  2. Everything else2625.3%
    1. Immunology and Microbiology1111.2%
  1. 1Oncology40% of their works
  2. 2Immunology11% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Surgery6% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Kevin M. Chin's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immune Checkpoint Blockade461 topic
  2. PD-1 and PD-L1461 topic
  3. Cancer Immunotherapy362 topics
  4. Lymphoma262 topics
  5. CAR T Cells191 topic
  6. Chimeric Antigen Receptor191 topic
  7. Dendritic Cells171 topic
  8. Immunity171 topic
  9. Fc Receptors121 topic
  10. Therapeutic Antibodies121 topic
  11. Merkel Cell Carcinoma111 topic
  12. Polyomavirus111 topic
  13. Breast Cancer71 topic
  14. Classification71 topic
  15. HER271 topic
  16. Molecular Profiling71 topic
  17. BRAF gene61 topic
  18. MAP Kinase61 topic

Where does Kevin M. Chin work?

Kevin M. Chin's main affiliation in the publication record is Merck KGaA, Darmstadt (Germany), Germany.

How many publications and citations does Kevin M. Chin have?

OpenAlex counts 102 works and 7,488 citations for Kevin M. Chin, an h-index of 29, ranking #547,492 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kevin M. Chin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.